USANA Health Sciences (USNA) Releases Earnings Results, Misses Expectations By $-0.04 EPS

USANA Health Sciences (USNA) reported quarterly earnings results on Tuesday, May-3-2016. The company reported $1.77 earnings per share for the quarter, missing the analyst consensus estimate by $-0.04. Analysts had a consensus of $1.81. The company posted revenue of $240.45 million in the period, compared to analysts expectations of $244.05 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.50 EPS.

Many Wall Street Analysts have commented on USANA Health Sciences. Shares were Downgraded by DA Davidson on Feb 10, 2016 to ” Neutral” and Lowered the Price Target to $ 130 from a previous price target of $155 .

USANA Health Sciences closed down -0.26 points or -0.22% at $118.18 with 2,27,663 shares getting traded on Monday. Post opening the session at $118.21, the shares hit an intraday low of $117.44 and an intraday high of $120.43 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

In a different news, on Apr 14, 2016, Myron W Wentz (director) sold 10,000 shares at $121.82 per share price. According to the SEC, on Mar 4, 2016, Jerry G Mcclain (director) sold 767 shares at $118.17 per share price. On Feb 26, 2016, Gilbert A Fuller (director) sold 728 shares at $113.22 per share price, according to the Form-4 filing with the securities and exchange commission.

USANA Health Sciences Inc. develops and manufactures science-based nutritional and personal care products. The Company has operations in approximately 19 markets across the world where it distributes and sells its products by way of direct selling. The Company operates as a direct selling company and reports revenue in two geographic regions: Americas and Europe and Asia Pacific which includes three sub-regions as: Southeast Asia Pacific Greater China and North Asia. Americas and Europe includes the United States Canada Mexico Colombia the United Kingdom France Belgium and the Netherlands. Southeast Asia Pacific includes Australia New Zealand Singapore Malaysia the Philippines and Thailand; Greater China includes Hong Kong Taiwan and China and North Asia includes Japan and South Korea.

USANA Health Sciences

Leave a Reply

USANA Health Sciences - Is it time to Sell?

Top Brokerage Firms are advising their investors on USANA Health Sciences. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.